FMCG manufacturer Danone has reported strong results for its FY25 results, with sales increasing by 4.5 per cent on a like-for-like basis to around £23.8bn.

The parent company of Activia and Actimel experienced a sales decrease of 0.3 per cent on a reported basis due to the negative impact of forex.

Sales across the European market went up by 2.5 per cent on a like-for-like basis to around £8.5bn, driven by a strong performance in the fourth quarter.

In particular, the Specialised Nutrition category has a standout delivery in Adult Medical Nutrition, while the momentum was strong in Waters too.

Subscribe to Grocery Gazette for free

Sign up here to get the latest grocery and food news each morning

The business saw also its volume/mix go up by 2.7 per cent and price rise by 1.8 per cent.

Antoine de Saint-Affrique, CEO of Danone said: “In 2025, we again delivered broad‑based, quality growth, reaffirming the strength and resilience of our health‑focused portfolio.

“Looking ahead to 2026, in a world that remains volatile, we remain disciplined and fully committed to our science-based and consumer- and patient-centric approach. We enter the year with confidence, aligned with the midterm ambition we have set out.”

The company’s total net income fell to around £1.6bn compared to around £1.8bn in the same period last year.

Moving forward, Danone forecasted like-for-like sales growth of between 3 per cent and 5 per cent.